Doctors Test a Controversial Migraine Remedy… And It Works

If you’ve ever suffered a migraine, you know it’s not “just a headache.” It can feel like a jackhammer behind your eyes, light that stabs like a dagger, and waves of nausea that stop you in your tracks.

Now, a new study brings some surprising—and natural—relief.

In the first-ever placebo-controlled human trial of cannabis for migraine, researchers found that vaporized cannabis—specifically a mix of THC and CBD—relieved pain and reduced symptoms faster and more effectively than a placebo.

This wasn’t just anecdotal or “stoner science.” This was a tightly controlled study conducted by neurologists at UC San Diego and presented at this year’s American Headache Society meeting.

Participants in the study self-treated a moderate-to-severe migraine attack using one of four options: THC, CBD, a combination of the two, or a placebo. They were not allowed to use any other pain relief until two hours after the treatment—giving researchers a clear window into how well each option worked.

Here’s what they found:

• 69% of people in the THC group and 67% in the THC/CBD group reported pain relief at two hours—compared to just 47% in the placebo group.
• The combination group (THC/CBD) also showed the highest rate of full pain freedom (nearly 35%), and it reduced migraine symptoms like light and sound sensitivity more effectively than either THC or CBD alone.

Even better? The THC/CBD blend provided stronger relief with fewer side effects than THC alone—thanks to CBD’s ability to temper THC’s more psychoactive effects.

Although cannabis users in the study did report mild euphoria or drowsiness, no serious adverse events occurred. No emergency visits. No panicked phone calls. And most patients couldn’t even tell whether they had received cannabis or a placebo—suggesting a well-designed trial with real, meaningful results.

Many migraine sufferers turn to cannabis out of desperation, especially when traditional treatments fail. But until now, there hasn’t been hard science to back them up.

This new trial changes that.

Still, the lead researcher cautions against overuse. Frequent cannabis use could lead to rebound headaches—so this option may be best reserved for occasional use or when other treatments fall short.

If you or a loved one struggles with migraine, this study offers hope—and potentially a new path forward. It also signals a shift in how the medical world views cannabis: not as a fringe option, but as a valid therapy worth further research.

Of course, not all cannabis products are created equal. This study used vaporized whole flower, not gummies, edibles, or oils. The delivery method, dosage, and ratio of THC to CBD matter.

And most importantly, consult your doctor before adding cannabis to your migraine toolkit—especially if you’re on other medications.

In the meantime, keep this in your back pocket. Relief may be greener than you think.

To clearer heads—and better options,

Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team

Sources:

Craven, J. (2025, July 10). Cannabis Cuts Migraine Symptoms in First Placebo-Controlled Trial. Medscape. https://www.medscape.com/viewarticle/cannabis-cuts-migraine-symptoms-first-placebo-controlled-2025a1000iad